Posted by Michael Wonder on 06 Jul 2018
Agenda for July 11 TC meeting
5 July 2018 - HAS has posted the agenda for the next scheduled TC meeting.
The Transparency Commission will consider the reimbursement of Allogeneic T cells modified with a retroviral vector (Zalmoxis)
